Loading…
Lobbying Income
$33.4M
Filings
1,197
Unique Clients
44
Active Period
2004–2019
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Improving Transparency and Accuracy in Medicare Part D Spending Act
2018 · fourth_quarter · Client: PRIME THERAPEUTICS
H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); S.771 & H.R. 1776-Improving Access to Affordable Prescription Drugs Act; H.R.1316-The Prescription Drug Price Transparency Act; HHS-OIG rule RIN -936-AAO8 entitled, Removal of Safe Harbor Protections for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1038
Prescription Drug Price Transparency Act
2018 · fourth_quarter · Client: PRIME THERAPEUTICS
H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); S.771 & H.R. 1776-Improving Access to Affordable Prescription Drugs Act; H.R.1316-The Prescription Drug Price Transparency Act; HHS-OIG rule RIN -936-AAO8 entitled, Removal of Safe Harbor Protections for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection.
Client expense: — · Firm income: $30,000
Matched citations: H.R.1316
Improving Access To Affordable Prescription Drugs Act
2018 · fourth_quarter · Client: PRIME THERAPEUTICS
H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); S.771 & H.R. 1776-Improving Access to Affordable Prescription Drugs Act; H.R.1316-The Prescription Drug Price Transparency Act; HHS-OIG rule RIN -936-AAO8 entitled, Removal of Safe Harbor Protections for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1776
H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES);HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2212
Improving Transparency and Accuracy in Medicare Part D Spending Act
2018 · fourth_quarter · Client: PRIME THERAPEUTICS
H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); S.771 & H.R. 1776-Improving Access to Affordable Prescription Drugs Act; H.R.1316-The Prescription Drug Price Transparency Act; HHS-OIG rule RIN -936-AAO8 entitled, Removal of Safe Harbor Protections for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection.
Client expense: — · Firm income: $30,000
Matched citations: S.413
Improving Access To Affordable Prescription Drugs Act
2018 · fourth_quarter · Client: PRIME THERAPEUTICS
H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); S.771 & H.R. 1776-Improving Access to Affordable Prescription Drugs Act; H.R.1316-The Prescription Drug Price Transparency Act; HHS-OIG rule RIN -936-AAO8 entitled, Removal of Safe Harbor Protections for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection.
Client expense: — · Firm income: $30,000
Matched citations: S.771
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
2018 · fourth_quarter · Client: PRIME THERAPEUTICS
H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES);HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
Client expense: — · Firm income: $30,000
Matched citations: S. 974
H.R. 2212 & S. 974, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act; S. 2476-Expanding Access to Low Cost Generic Drugs Act; Issues relating to generic drug pricing; Public Law 115-52 (The FDA Reauthorization Act of 2017)section 808 relating to the Competitive Generic Therapy ("CGT") designation.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2212
Expanding Access to Low Cost Generic Drugs Act
2018 · fourth_quarter · Client: APOTEX CORPORATION
H.R. 2212 & S. 974, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act; S. 2476-Expanding Access to Low Cost Generic Drugs Act; Issues relating to generic drug pricing; Public Law 115-52 (The FDA Reauthorization Act of 2017)section 808 relating to the Competitive Generic Therapy ("CGT") designation.
Client expense: — · Firm income: $50,000
Matched citations: S. 2476
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
2018 · fourth_quarter · Client: APOTEX CORPORATION
H.R. 2212 & S. 974, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act; S. 2476-Expanding Access to Low Cost Generic Drugs Act; Issues relating to generic drug pricing; Public Law 115-52 (The FDA Reauthorization Act of 2017)section 808 relating to the Competitive Generic Therapy ("CGT") designation.
Client expense: — · Firm income: $50,000
Matched citations: S. 974
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2018 · fourth_quarter · Client: HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC
S.1304 & H.R. 1920 relating to customary prompt pay discounts from manufacturers to wholesalers from the average sales price.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1920
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
2018 · fourth_quarter · Client: HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC
Issues related to the HHS RFI on the Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs; S.2852 & H.R. 6378-Pandemic All-Hazards Preparedness Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6378
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2018 · fourth_quarter · Client: HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC
S.1304 & H.R. 1920 relating to customary prompt pay discounts from manufacturers to wholesalers from the average sales price.
Client expense: — · Firm income: $60,000
Matched citations: S.1304
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
2018 · fourth_quarter · Client: HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC
Issues related to the HHS RFI on the Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs; S.2852 & H.R. 6378-Pandemic All-Hazards Preparedness Act.
Client expense: — · Firm income: $60,000
Matched citations: S.2852
Affordable and Safe Prescription Drug Importation Act
2018 · fourth_quarter · Client: HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC
Public Law 115-271-SUPPORT for Patients and Communities Act; S.469-The Affordable and Safe Prescription Drug Importation Act; Public Law 114-145-The Ensuring Patient Access and Effective Drug Enforcement Act.
Client expense: — · Firm income: $60,000
Matched citations: S.469
Shared Accountability for Improved Patient Outcomes Act of 2018
2018 · fourth_quarter · Client: Medtronic, Inc.
H.R. 7177-Shared Accountability for Improved Patient Outcomes Act of 2018; Draft Senate legislation to amend the Social Security Act to promote value-based arrangements; Issues relating to anti-kickback and physician self-referral prohibitions relating to healthcare value-based arrangements.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7177
H.R.2212 & S.974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.
Client expense: — · Firm income: $20,000
Matched citations: H.R.2212
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
2018 · fourth_quarter · Client: LUPIN PHARMACEUTICALS INC
H.R.2212 & S.974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.
Client expense: — · Firm income: $20,000
Matched citations: S.974
Stopping EPA Overreach Act of 2017
2018 · fourth_quarter · Client: HOOPER LUNDY & BOOKMAN P C (OBO ROCHE DIAGNOSTICS)
S. 2852 & H.R.637/H.R.7328-The Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018.
Client expense: — · Firm income: $20,000
Matched citations: H.R.637
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
2018 · fourth_quarter · Client: HOOPER LUNDY & BOOKMAN P C (OBO ROCHE DIAGNOSTICS)
S. 2852 & H.R.637/H.R.7328-The Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018.
Client expense: — · Firm income: $20,000
Matched citations: H.R.7328
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
2018 · fourth_quarter · Client: HOOPER LUNDY & BOOKMAN P C (OBO ROCHE DIAGNOSTICS)
S. 2852 & H.R.637/H.R.7328-The Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018.
Client expense: — · Firm income: $20,000
Matched citations: S. 2852
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2018 · third_quarter · Client: HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC
S.1304 & H.R. 1920 relating to customary prompt pay discounts from manufacturers to wholesalers from the average sales price.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1920
SUPPORT for Patients and Communities Act
2018 · third_quarter · Client: HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC
H.R.6-SUPPORT for Patients and Communities Act relating to S.2838-Using Data to Prevent Opioid Diversion Act & S.2837-The Preventing Drug Diversion Act; S.2852 & H.R. 6378-Pandemic All-Hazards Preparedness Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R.6
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
2018 · third_quarter · Client: HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC
H.R.6-SUPPORT for Patients and Communities Act relating to S.2838-Using Data to Prevent Opioid Diversion Act & S.2837-The Preventing Drug Diversion Act; S.2852 & H.R. 6378-Pandemic All-Hazards Preparedness Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6378
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2018 · third_quarter · Client: HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC
S.1304 & H.R. 1920 relating to customary prompt pay discounts from manufacturers to wholesalers from the average sales price.
Client expense: — · Firm income: $60,000
Matched citations: S.1304
Source: Senate LDA